Result | Filter: | |||||||||||||||||||||||
ID | SEQUENCE | LENGTH | VIRUS | INHIBITION/ IC50 |
UNIT | TARGET | ASSAY | PMID | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVP0088 | PDAVYLHRIDLGPPISLERLDVGTNLGNAIAKLED | 35 | MV | >100 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0089 | DAVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDA | 35 | MV | >100 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0090 | AVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAK | 35 | MV | >100 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0091 | VYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAKE | 35 | MV | 85.3 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0092 | YLHRIDLGPPISLERLDVGTNLGNAIAKLEDAKEL | 35 | MV | 90.7 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0093 | LHRIDLGPPISLERLDVGTNLGNAIAKLEDAKELL | 35 | MV | 1.5 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0094 | HRIDLGPPISLERLDVGTNLGNAIAKLEDAKELLE | 35 | MV | 2.2 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0095 | RIDLGPPISLERLDVGTNLGNAIAKLEDAKELLES | 35 | MV | 1.7 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0096 | IDLGPPISLERLDVGTNLGNAIAKLEDAKELLESS | 35 | MV | 4.9 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0097 | DLGPPISLERLDVGTNLGNAIAKLEDAKELLESSD | 35 | MV | 5.7 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0098 | LGPPISLERLDVGTNLGNAIAKLEDAKELLESSDQ | 35 | MV | 6.5 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0099 | GPPISLERLDVGTNLGNAIAKLEDAKELLESSDQI | 35 | MV | 10.1 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0100 | PPISLERLDVGTNLGNAIAKLEDAKELLESSDQIL | 35 | MV | 1.1 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0101 | PISLERLDVGTNLGNAIAKLEDAKELLESSDQILR | 35 | MV | 3.1 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0102 | ISLERLDVGTNLGNAIAKLEDAKELLESSDQILRS | 35 | MV | 13 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0103 | SLERLDVGTNLGNAIAKLEDAKELLESSDQILRSM | 35 | MV | 12.3 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0104 | LERLDVGTNLGNAIAKLEDAKELLESSDQILRSMK | 35 | MV | 7.3 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0144 | IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH | 35 | MV | 0.015 | EC50 (μM) | Fusion | Cytopathic effect | |||||||||||||||||
AVP0159 | ISLERLDVGTNLGNAIAKLEDAKELLESSDQILRSM | 36 | MV | 20 | nM | Fusion | Hemolysis assay | |||||||||||||||||
AVP1402 | LHRIDLGPPISLERLDVGTNLGNAIAKLEAKELL | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1403 | HRIDLGPPISLERLDVGTNLGNAIAKLEAKELLE | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1404 | RIDLGPPISLERLDVGTNLGNAIAKLEAKELLES | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1405 | IDLGPPISLERLDVGTNLGNAIAKLEAKELLESS | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1406 | DLGPPISLERLDVGTNLGNAIAKLEAKELLESSD | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1407 | LGPPISLERLDVGTNLGNAIAKLEAKELLESSDQ | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1408 | GPPISLERLDVGTNLGNAIAKLEAKELLESSDQI | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1409 | PPISLERLDVGTNLGNAIAKLEAKELLESSDQIL | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1410 | PISLERLDVGTNLGNAIAKLEAKELLESSDQILR | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1411 | SLERLDVGTNLGNAIAKLEAKELLESSDQILRSM | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1412 | LERLDVGTNLGNAIAKLEAKELLESSDQILRSMK | 34 | MV | High | - | Fusion | Cell-fusion assay | |||||||||||||||||
AVP1920 | SGFDPLITHA | 10 | MV | High | NA | Virus entry | ELISA | |||||||||||||||||
AVP1921 | SDWDPLFTHK | 10 | MV | High | NA | Virus entry | ELISA | |||||||||||||||||
AVP1993 | PPATHTIADRNHTPFSDV | 18 | MV | 0.33 | μM(EC50) | Virus entry | Fluorescence assay | |||||||||||||||||
AVP1994 | ATHTICDRNHTW | 12 | MV | 60 | μM(EC50) | Virus entry | Fluorescence assay | |||||||||||||||||
AVP2049 | LFGLIPSLIGGLVSAFK | 17 | MV | 3.52 | μM(EC50) | Replication | Plaque assay | |||||||||||||||||
AVP2050 | LFRLIKSLIKRLVSAFK | 17 | MV | No | NA | Replication | Plaque assay | |||||||||||||||||
AVP2051 | SLIGGLVSAFK | 11 | MV | No | NA | Replication | Plaque assay | |||||||||||||||||
AVP2052 | VSAFK | 5 | MV | No | NA | Replication | Plaque assay | |||||||||||||||||